Guangzhou Baiyunshan Pharmaceutical Holdings Company LimitedSSE: 600332

Announcement on Implementation of Dividend Distribution for 2025

Jun 10, 2026 · Issued by Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited via Shanghai Stock Exchange

Filed with SSE · Jun 10, 2026 · 3 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-implementation-of-dividend-distribution-for-2025-937

Release

Announcement on Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited on 6ix

Earlier from Guangzhou Baiyunshan Pharmaceutical

Announcement on Completing Term Change of the Board of Directors and Appointing Senior Management MembersMay 30
Announcement on Election of Employee Representative DirectorMay 16
Announcement on Convening Performance Briefing for 2025 and Q1 2026May 15
Announcement on Obtaining Notice of Approval for Drug Supplementary Application by a SubsidiaryMay 12
Announcement on Election of Board of Directors at Expiry of Term of OfficeMay 8

Later from Guangzhou Baiyunshan Pharmaceutical

Announcement on Branch Receiving Drug Registration CertificateJun 11
"Corporate Value and Return Enhancement" Action Plan 2026Jun 23
Announcement on Completion of Legal Representative Change Registration and Renewal of Business LicenseJul 1
Announcement on Subsidiary's Drug Passing Generic Drug Consistency EvaluationJul 10
Indicative Announcement on the Pre-Listing of the Capital Increase and Share Expansion of a SubsidiaryJul 11

All Guangzhou Baiyunshan Pharmaceutical news releases

Follow Guangzhou Baiyunshan Pharmaceutical into a list and get an email when it puts out news.

Follow Guangzhou Baiyunshan Pharmaceutical